Trinity Biotech (TRIB)

[oilin07]

Bought right back up

[Monksdream]

TRIB new 52 week low

[oilin07]

Get ready for take off

[StockLogistics]

Close at .98 would be a nice double bottom, .80 gap as well from March 2020, say somewhere in the mid .70s as a buying opportunity imo

[stocks2watch]

Today.

[oilin07]

It should soon

[HeilHiden]

When’s this going to switch on us

[HeilHiden]

Or new highs

[StockLogistics]

2 months and 10 days to new all time lows below .56

[StockLogistics]

Still building that eifeil tower on the 5 year chart .63 - .70 cents a share completes the tower

[StockLogistics]

“ The White House is also purchasing 500 million at-home Covid tests that Americans can order for free through a website starting in January.” - CNBC breaking news

Let’s rock!

[HeilHiden]

Let’s climb!!

[StockLogistics]

Big day today, company could release news today, Re-enter:

[HeilHiden]

1.58 high for the day

[StockLogistics]

BOOM Trinity big day today and tomorrow

[StockLogistics]

“ One pill makes you larger
And one pill makes you small,
And the ones that mother gives you
Don't do anything at all.
Go ask Alice
When she's ten feet tall.
And if you go chasing rabbits
And you know you're going to fall,
Tell 'em a hookah smoking caterpillar
Has given you the call.
Call Alice
When she was just small.
When the men on the chessboard
Get up and tell you where to go
And you've just had some kind of mushroom
And your mind is moving low.
Go ask Alice
I think she'll know.
When logic and proportion
Have fallen sloppy dead,
And the White Knight is talking backwards
And the Red Queen's "off with her head!"
Remember what the dormouse said:
"Feed your head. Feed your head. Feed your head"
Source: Musixmatch
Songwriters: Grace Slick
White Rabbit lyrics © Copperpenny Music”

[StockLogistics]

Matrix 4 12/22/21

[StockLogistics]

In for Matrix 4 and Trinity correlation let’s go to 30.00

[HeilHiden]

You used to be a good poster last year I remember you. Now you’re a fear monger!

[HeilHiden]

It’s better than 80 million release of new shares to pay the old debt. Refinancing is in our best interest. With the company turning a profit and with Africa hiv testing still not rebooted there’s huge potential upside in the coming year.

[StockLogistics]

It’s a good deal to pay 8 million + in loan interest a year ?

[HeilHiden]

600k a month

[HeilHiden]

With over 100 million in revenues a year and market cap being around 30 mil were highly undervalued as medical companies usually trade at multiple of their revenues

[HeilHiden]

Good deal all of it!

[StockLogistics]

11% annual rate is more than 8 million a year in loan interest.

“ Quarter 3 2021 Results

Total revenues for Q3, 2021 were $22.0m, which compares to $32.0m in Q3, 2020, a decrease of $10.0m”

This company’s revenues could sustain that type of debt if its profit margin was very high and if it had no other expenses.

“ Operating profit for the quarter was $2.8m, which represents a decrease of $6.3m compared to Q3, 2020 and was attributable to lower revenues and gross margin offset slightly by lower indirect costs and higher other operating income.”

[StockLogistics]

“ The Company and its subsidiaries entered into a $81,250,000 senior secured term loan credit facility (the “Term Loan”) with Perceptive Advisors (“Perceptive”), an investment manager with an expertise in healthcare. Proceeds from the Term Loan, along with existing cash and the issuance of new American Depository Shares (“ADS”) in the Company, will be used to retire substantially all of the Notes.

The Term Loan will mature on the fourth anniversary of the closing date and accrues interest at an annual rate equal to 11.25% plus the greater of (a) one-month LIBOR and (b) one percent per annum, and interest will be payable monthly in arrears in cash. The Term Loan does not require any amortization, and the entire unpaid balance will be payable upon maturity.

The funding of the Term Loan is subject to a number of conditions precedent including the repayment of at least 99.7% of the Notes and approval by the Company’s shareholders of the Term Loan, an increase in the authorized share capital of the Company and the issuance of the Warrants. The Company intends to convene a general meeting of the Company to consider these matters in January 2022.

In connection with the Term Loan, the Company has agreed, subject to drawdown of the Term Loan, to issue warrants (the “Warrants”) exercisable for 2,500,000 of the Company’s ADSs to Perceptive. The per ADS exercise price of the Warrants is equal to the lower of i) the 10-day volume weighted average price (“VWAP”) for the Company’s ADSs for the 10 business days prior to December 15, 2021 and ii) the 10-day VWAP for the Company’s ADSs for the 10 business days prior to the drawdown date of the funding under the Term Loan. The Warrants are exercisable, in whole or part, until the seventh anniversary of the date of drawdown of the funding under the Term Loan.

In addition to the Term Loan, the Company has entered into exchange agreements (the “Exchange Agreements”) with five institutional investors that hold approximately $99.7million of the outstanding Notes, which are puttable by the Holders in April 2022. Under the terms of this agreement each holder will receive $ 0.87 of cash and the equivalent of $0.08 of the Company’s ADS (based upon the 5-day volume weighted average price for the Company’s ADSs for the 5 business days prior to December 10, 2021, discounted by 13%) per $1 nominal value of the Notes. The consummation of the Exchange Agreements is conditional upon (among other things) the approval by the Company’s shareholders of the issuance of ADSs pursuant to the Exchange Agreements and certain matters related to the funding of the Term Loan, with such approvals to be included in the agenda of the January 2022 general meeting of the Company.

Two of the Company’s existing board members, Jim Walsh and Kevin Tansley, have announced their intention to retire from the Company’s board in the coming months. The Company intends to retain an internationally recognized executive search firm to identify three suitably experienced and qualified candidates to join the Company’s board as independent directors. Following these appointments, the Company’s board will consist of five independent non-executive directors and two executive directors, Mr. Ronan O’Caoimh, Chairman and Chief Executive Officer and Mr. John Gillard, Chief Financial Officer. As part of this process the Company will seek to increase the diversity of its board membership.”

https://www.otcmarkets.com/filing/html?id=15423788&guid=jdfwkePL-zw-B3h

[HeilHiden]

Can’t wait for Monday!

[HeilHiden]

One buyer takes us up multiple cents. The coming trading periods will play nicely here. First the U.S economy is in full recovery mode. Next the worldwide economy boots up. With Trinity Biotech being in the medical sphere Covid testing has taken off for the company producing additional revenues. The companies main business of HIV testing in Africa has ultimately been replaced by other company activity. With worldwide transportation opening up the HIV testing will put us even further in the green. Increasing revenues and profits substantially.

[HeilHiden]

Current spread is 4 cents. 1.52 bid 1.56 ask

[HeilHiden]

Ask is thin. Company restructuring debt for a more beneficial option to shareholders. All good news and more to come. Trading below revenues best value option for the coming trading periods.

[StockLogistics]

“In connection with the Term Loan the Company has agreed, subject to drawdown of the Term Loan, to issue warrants (the "Warrants") exercisable for 2,500,000 of the Company's ADSs to Perceptive. The per ADS exercise price of the Warrants is equal to the lower of i) the 10-day volume weighted average price ("VWAP") for the Company's ADSs for the 10 business days prior to the Closing Date of the Credit Agreement for the Term Loan and ii) the 10-day VWAP for the Company's ADSs for the 10 business days prior to the drawdown date of the funding under the Term Loan. The Warrants are exercisable, in whole or part, until the seventh anniversary of the date of drawdown of the funding under the Term Loan.

The drawdown of the Term Loan by the Company is subject to a number of conditions precedent including the repayment of at least 99.7% of the Notes and approval by the Company's shareholders of the Term Loan, an increase in the authorized share capital of the Company and the issuance of the Warrants. The Company intends to convene a general meeting of the Company to consider these and other matters in January 2022 and intends to issue a notice convening such meeting in the coming days.

In addition to the Term Loan, the Company has entered into exchange agreements (the "Exchange Agreements") with five institutional investors that hold approximately $99,700,000 of the outstanding Notes, which are puttable by the holders to the Company, at par, in April 2022. Under the terms of this agreement each holder has agreed to exchange their Notes at a discount to par and each holder will receive $0.87 of cash and the equivalent of $0.08 of the Company's ADS (based upon the 5-day trailing VWAP of the ADSs on NASDAQ on December 9, 2021, discounted by 13%) per $1 nominal value of the Notes. This results in an effective discount on the exchange of the Notes of approximately 4%. The consummation of the Exchange Agreements is conditional upon (among other things) the approval by the Company's shareholders of the issuance of ADSs pursuant to the Exchange Agreements and certain matters related to the drawdown of the Term Loan, with such approvals to be included in the agenda of the January 2022 general meeting of the Company.”

.68 cents today then release hiv test approval news tomorrow

[HeilHiden]

Saw it today!

[HeilHiden]

The lower we go the more a buy will push us up. Value investors know to hold their shares until they pay for their mortgage, vacation, or Christmas.

[StockLogistics]

December 14 next chart opportunity imo, .68 cent gap fill as possible close price

[HeilHiden]

Value stock over perform during times of market decline so I’ll be patient it just hasn’t had a bug buyer come in yet. A lot of watchers on this one. When the value comes well all feel it

[HeilHiden]

It’s a value stock is why I’m in

[StockLogistics]

Six month consolidation ends today, should have news soon therefore imo

[StockLogistics]

There is a gap at .68 cents and I think the market is spooked by the possibility of increased tax selling because of the laws being passed in Congress, this company could provide a PR, last one was 10/18/21

[HeilHiden]

Let’s rolllll

[HeilHiden]

$100,000 order at $2.00

[HeilHiden]

It’s very undervalued and it’s time will come. Probably when the EPS shows a profit for a year. Or if they brought back the dividend.

[StockLogistics]

Two and half months I tried to provide my opinion on this stock,
The numbers were great, but the market disagrees about the future, all it did was decrease in this time frame, they have to put news out, the matrix angle to this ended up being nucypher and keep crypto mooning, not trinity, all imo.

[HeilHiden]

$TRIB’s African HIV testing will also be coming back as pandemic ends adding to the profits!

[HeilHiden]

How about the profit last quarter?

[StockLogistics]

Could see a bit of a downturn here without something substantial from the company monday, chart not looking good, on the last leg of the Eiffel Tower to the down side to retest .62 all time low possible, I think people are expecting the pandemic to end soon, all imo

[StockLogistics]

Reminds me of RAP# which traded in the $17 area and then moved to $40 in one day

RAP#

Share Structure

Market Cap Market Cap
876,099,384
10/12/2021
Authorized Shares
Not Available
Outstanding Shares
29,488,367
08/06/2021
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
No Par Value

TRIB

Share Structure

Market Cap Market Cap
12,541,022
08/20/2021
Authorized Shares
Not Available
Outstanding Shares
20,901,703
12/31/2019
Restricted
Not Available
Unrestricted
Not Available
Held at DTC
Not Available
Float
Not Available
Par Value
No Par Value

[StockLogistics]

10:13a ET 10/8/2021 - Benzinga
Trinity Biotech Subsidiary Biopool U.S. Wins Defense Logistic Agency Contract Worth Up To $4M

https://dibbs2.bsm.dla.mil/Downloads/Awards/07OCT21/SPE2DE22D0001.PDF

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Investors like additional Revenue streams imo

[HeilHiden]

Agreed!

[oilin07]

EXTREMELY UNDERVALUED

[HeilHiden]

20 cent EPS. This is a monster awakening!